Viscosupplementation for the treatment of osteoarthritis of the knee

Cochrane Database of Systematic Reviews

Volumn 2006, Issue 2, 2006, Pages

  Bellamy, Nicholas ^a   Campbell, Jane ^b   Welch, Vivian ^c   Gee, Travis L ^a   Bourne, Robert ^b   Wells, George A ^c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTHRUM H; CORTICOSTEROID; EUFLEXXA; FERMATHRON; GO ON; HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; NUFLEXXA; REPLASYN; SLM 10; SYNJECT; ZEEL COMPOSITUM; DRUG DERIVATIVE; HYLAN;

ARTHROCENTESIS; ARTHROSCOPY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EXERCISE; FOLLOW UP; FUNCTIONAL ASSESSMENT; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; KNEE OSTEOARTHRITIS; LONG TERM CARE; MOLECULAR WEIGHT; PHYSIOTHERAPY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; THERAPY EFFECT; TIME TO TREATMENT; TREATMENT OUTCOME; VISCOSUPPLEMENTATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; ANALOGS AND DERIVATIVES; INTRAARTICULAR DRUG ADMINISTRATION; OSTEOARTHRITIS, KNEE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

HUMANS; HYALURONIC ACID; OSTEOARTHRITIS, KNEE; RANDOMIZED CONTROLLED TRIALS; INJECTIONS, INTRA-ARTICULAR; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84925558062     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD005321.pub2     Document Type: Review

References (402)

1. Adams ME, Atkinson MH, Lussier AJ, Schulz JI, Siminovitch KA, Wade JP, Zummer M. The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis and Cartilage 1995;3:213-6.
2. Altman RD, Moskowitz R, the Hyalgan Study Group. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial [published erratum appears in J Rheumatol 1999;26:1216]. The Journal of Rheumatology 1998;25(11):2203-12.
3. Altman RD, Akermark C, Beaulieu AD, Schnitzer T for the Durolane International Study Group. Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee. Osteoarthritis and Cartilage 2004;12(8):642-9.
4. Ardic F, Bolulu D, Topuz O, Cubukcu S. Efficacy of intra-articular hyaluronic acid injections in knee osteoarthritis. Annals of the Rheumatic Diseases 2001;60 Suppl (1):232.
5. Atamaz F, Kirazli Y, Akkoc Y. A comparative study between intra-articular hylan G-F 20 and Na-hyaluronate and physical therapy in the management of knee osteoarthritis. Annals of the Rheumatic Diseases 2004;EULAR, Berlin, June 9-12.
6. Atamaz F, Kirazli Y, Akkoca Y. A comparison of two different intra-articular hyaluronan drugs and physical therapy in the management of knee osteoarthritis. Rheumatology International 2006;26(10):873-8.
7. Auerbach B, Melzer C. Cross-linked hyaluronic acid in the treatment of osteoarthritis of th eknee - results of a prospective randomized trial [Die Behandlung der Gonarthrose mit hochvernetzter Hyaluronsaure - Ergebnisse einer prospektiven randomisierten Studie]. Zentralblatt fur Chirurgie 2002;127(10):895-9.
8. Auerbach B. [Ergebnisse einer prospektiven randomisierten Studie zur Wirksamkei hochvernetzter Hyaluronsaure bei der Behandlung der Gonarthrose]. Inaugural-Dissertation zur Erlangung des Grades eines Doktors der Medizin des Fachbereichs Humanmedizin der Justus-Liebig-Universitat Giessen 2002.
9. Bayramoglu M, Karatas M, Cetin N, Akman N. Comparison of two different viscosupplements in knee osteoarthritis - a pilot study. Clinical Rheumatology 2003;22:118-2.
10. Bragantini A, Cassini M, De Bastiani G. Controlled single-blind trial of intra-articularly injected hyaluronic acid (Hyalgan) in osteo-arthritis of the knee. Clinical Trials Journal 1987;24(4):333-40.
11. Brandt KD, Block JA, Michalski JP, Moreland LW, Caldwell JR, Lavin PT, the ORTHOVISC Study Group. Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. Clinical Orthopaedics and Related Research 2001;385:130-43.
12. Brown DJ, Beinat L. Safety and efficacy of an hyaluronan of 500-730 KDa and Hylan G-F 20 in clinical practice. Osteoarthritis and Cartilage 2003;11 Suppl (A):118. [: OARSI October 2003 Berlin].
13. Bunyaratavej N, Chang KM, Subramanian N. Treatment of painful osteoarthritis of the knee with hyaluronic acid results of a multicenter Asian study. Journal of the Medical Association of Thailand 2001;84 Suppl (2):576-81.
14. Caborn DN. Efficacy and tolerability of hylan G-F 20 compared to intra-articular triamcinolone hexacetonide in patients with osteoarthritis of the knee in a randomized, evaluator-blinded study. Annals of the Rheumatic Diseases 2003;EULAR, Lisbon, Portugal, June 18-21.
15. Caborn D, Rush J, Lanzer W, Parenti D, Murray C on Behalf of the Synvisc 901 Study Group. A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. The Journal of Rheumatology 2004;31(2):333-43.
16. Carrabba M, Paresce E, Angelini M, Re KA, Torchiana EEM, Perbellini A. The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. European Journal of Rheumatology and Inflammation 1995;15(1):25-31.
17. Reference same as Carrabba 1995, multiple arm trial.
18. Reference same as Carrabba 1995, multiple arm trial.
19. Reference same as Carrabba 1995, multiple arm trial.
20. Cohen MA, Shiroky JB, Ballachey ML, Neville C, Esdaile JM. Double-blind randomized trial of intra-articular (I/A) hyaluronate in the treatment of osteoarthritis of the knee. Arthritis & Rheumatism 1994;37 Suppl 6:R31.
21. Corrado EM, Peluso GF, Gigliotti S, de Durante C, Palmieri D, Savoia M, Oriani GO, Tajana GF. The effects of intra-articular administration of hyaluronic acid on osteoarthritis of the knee: a clinical study with immunological and biochemical evaluations. European Journal of Rheumatology and Inflammation 1995;15(1):47-56.
22. Creamer P, Sharif M, George E, Meadows K, Cushnaghan J, Shinmei M, Dieppe P. Intra-articular hyaluronic acid in osteoarthritis of the knee: an investigation into mechanisms of action. Osteoarthritis and Cartilage 1994;2:133-40.
23. Cubukcu D, Ardic F, Karabulut N, Topuz O. Hylan G-F 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment. Clinical Rheumatology 2005;24(4):336-41.
24. Day R, Brooks P, Petersen M, The Australian Multicentre Trial Group. A randomised multicentre parallel group study of the effectiveness and tolerance of intra-articular injections of sodium hyaluronate in osteoarthritis of the knee.
25. Day R, Brooks P, Conaghan PG, Petersen M for the Multicenter Trial Group. A double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the knee. The Journal of Rheumatology 2004;31(4):775-82.
26. Dickson DJ, Hosie G, English JR, and the Primary Care Rheumatology Society. A double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. Journal of Clinical Research 2001;4:41-52.
27. Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthritis and Cartilage 1993;1:97-103.
28. Sala S, de Miguel RE. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: a short term study. European Journal of Rheumatology and Inflammation 1995;15(1):33-8.
29. Forster MC, Straw R. A prospective randomised trial comparing intra-articular Hyalgan injection and arthroscopic washout for knee osteoarthritis. The Knee 2003;10:291-3.
30. Forster MC, Straw R, Rowles JM. A prospective randomised trial comparing intra-articular sodium hyaluronate injection and arthro-scopic washout for knee osteoarthritis. The Journal of Bone and Joint Surgery 2003;85-B Suppl (II):103.
31. Frizziero L, Pasquali Rochetti I. Intra-articular treatment of osteoarthritis of the knee: an arthroscopic and clinical comparison between sodium hyaluronate (500-730 kDa) and methylprednisolone acetate. Journal of Orthopaedics and Traumatology 2002;3:89-96.
32. Graf J, Neusel E, Schneider E, Niethard FU. Intra-articular treatment with hyaluronic acid in osteoarthritis of the knee joint: a controlled clinical trial versus mucopolysaccharide polysulfuric acid ester. Clinical and Experimental Rheumatology 1993;11:367-72.
33. Grecomoro G, Martorana U, Di Marco C. Intra-articular treatment with sodium hyaluronate in gonarthrosis: a controlled clinical trial versus placebo. Pharmatherapeutica 1987;5(2):137-41.
34. Groppa LG, Moshneaga M. Studying of the efficiency of the Synvisc in osteoarthrosis. Annals of the Rheumatic Diseases 2001;60 Suppl (1):230.
35. Guler M, Kuran B, Parlar D, Guler M, Saglam H, Yapici S, Guzeloglu S, Ozgul Mese F, Bonveval F. Clinical trial of intra-articular injection of hyaluronic acid in patients with osteoarthritis of the knee. X National Rheumatology Congress, Turkey. October 29-November 3, 1996.
36. Henderson EB, Smith EC, Pegley F, Blake DR. Intra-articular injections of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy. Annals of the Rheumatic Diseases 1994;53:529-34.
37. See Henderson 1994.
38. Hizmetli S, Kocagil S, Kaptanoglu E, Elden H, Nacitarhan V. The efficacy and safety of intra-articular hyaluronic acid in osteoarthritis of the knee: a prospective, double-blind trial.
39. Huang M-H, Yang R-C, Lee C-L, Chen T-W, Wang M-C. Preliminary results of integrated therapy for patients with knee osteoarthritis. Arthritis Care & Research 2005;53(6):812-20.
40. Huskisson EC, Donnelly S. Hyaluronic acid in the treatment of osteoarthritis of the knee. Rheumatology 1999;38:602-7.
41. Jones AC, Pattrick M, Doherty S, Doherty M. Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthritis and Cartilage 1995;3:269-73.
42. Jubb RW, Piva S, Beinat L, Dacre J, Gishen P on behalf of the UK Hyalgan Study Group. Effect of sodium hyaluronate (500-730 KDa, HyalganR) on joint space width in osteoarthritis of the knee. The Journal of Rheumatology 2001;28 Suppl (63):8.
43. Jubb RW, Piva S, Beinat L, Dacre J, Gishen P for the UK Hyalgan Study Group. Structure modifying study of hyaluronan (500-730 KDa, HyalganR) on osteoarthritis of the knee. Osteoarthritis and Cartilage 2001;9 Suppl (B):16.
44. Jubb RW, Piva S, Beinat L, Dacre J, Gishen P. Structure modifying study of hyaluronan (500-730 KDa, HyalganR) on osteoarthritis of the knee. Arthritis & Rheumatism 2001;44 Suppl (9):155.
45. Jubb RW, Piva S, Beinat L, Dacre J, Gishen P, on behalf of the UK Hyalgan Study Group. Structure modification in osteoarthritis with intra-articular sodium hyaluronate of mol. 500-730 KDA. Annals of the Rheumatic Diseases 2001;60 Suppl (I):46.
46. Jubb RW, Piva S, Beinat L, Dacre J, Gishen P. A one-year, randomised, placebo (saline) controlled clinical trial of 500-730 kDa sodium hyaluronate (Hyalgan) on the radiological change in osteoarthritis of the knee. International Journal of Clinical Practice 2003;57(6):467-74.
47. Kahan A, Guemas E, Lieu PL. Patients with knee osteoarthritis treated by hylan G-F 20 versus usual treatments: a medico-economic, prospective, randomised large scale trial in France, efficacy and safety outcomes. Annals of the Rheumatic Diseases 2001;60 Suppl (1):232.
48. Kahan A, Lleu P-L, Salin L. Prospective randomised study comparing the medico-economic benefits of hylan GF-20 versus conventional treatment in knee osteoarthritis [Etude prospective randomisee comparant le benefice medico-economique de Synvisc a celui des traitements usuels chez des patients souffrant de gonarthrose]. Revue du rhumatisme 2003;70:588-94.
49. Kahan A, Lleu P-L, Salin L. Prospective randomized study comparing the medicoeconomic benefits of Hylan G-F 20 vs. conventional treatment in knee osteoarthritis. Joint Bone Spine 2003;70:276-81.
50. Kalay S. The effectiveness of intraarticular hyaluronic acid treatment in primary gonarthrosis [specialization thesis]. Ankara, Turkey: Ministry of Health, Republic of Turkey, 1997.
51. Karatay S, Kiziltunc A, Yildirim K, Karanfil RC, Senel K. Effects of different hyaluronic acid products on synovial fluid levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in knee osteoarthritis. Annals of Clinical & Laboratory Science 2004;34(3):330-5.
52. Karatay S, Kiziltunc A, Yildirim K, Karanfil RC, Senel K. Effects of different hyaluronic acid products on synovial fluid NO levels in knee osteoarthritis. Osteoporosis International 2005;16(3):S71.
53. Karatay S, Yildirim K, Yildiz L, Karanfil RC, Senel K. The effect of hyaluronic acid on levels of IFG-1 and IGFBP-3 in synovial fluids of patients with knee osteoarthritis. Osteoporosis International 2005;16(3):S72.
54. Karatosun V, Unver B, Gocen Z, Sen A, Gunal I. Intra-articular hyaluronic acid compared with progressive knee exercises in osteoarthritis of the knee: a prospective randomized trial with long-term follow-up. Clinical & Experimental Rheumatology 2005.
55. Karatosun V, Unver B, Gocen Z, Sen A. Comparison of two hyaluronan drugs in patients with advanced osteoarthritis of the knee. A prospective, randomized, double-blind study with long term follow-up. Clinical and Experimental Rheumatology 2005;23(2):213-8.
56. Karlsson J, Selin-Sjogren L. A comparison of two hyaluronan drugs and placebo in patients with mild to moderate osteoarthritis of the knee - a controlled, randomised, parallel-design multicenter study. Acta orthopaedica Scandinavica 1999;70 Suppl (287):62.
57. Karlsson J, Sjogren LS, Lohmander LS. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology 2002;41(11):1240-8.
58. See Karlsson 2002.
59. See Karlsson 2002.
60. See Karlsson 2002.
61. Karlsson J, Sjogren LS, Lohmander S. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology 2003;42(10):1262-3.
62. Karras D, Basilakos J, Diaourta V, Kedikoglou S, Iliopoulos A. Comparative study of 2 regimens of intraarticular infusion of hyaluronan (Hyalart, Fidia, SPA) in knee osteoarthritis. The Journal of Rheumatology 2001;28 Suppl (63):6.
63. Kawabata M, Igarashi M, Mikami R, Ninomiya S, Oda H, Hoshino Y, Yamamoto S, Kurokawa T, Ogawa N. Clinical evaluation of SLM-10 (sodium hyaluronate injection) in patients with osteoarthritis of the knee - a mutli-center comparative trial with Artz as control drug. Japanese Pharmacology & Therapeutics 1993;21(1):257-83.
64. Kirchner M, Marshall D. A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthritis and Cartilage 2006;14(2):154-62.
65. Kirchner M, Marshall D. A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthritis and Cartilage 2006;14(2):154-62.
66. Kotevoglu N, Iyibozkurt P, Hiz O, Kuran B. Viscosupplementation treatment for osteoarthritis of the knee. Annals of the Rheumatic Diseases 2002;61 Suppl.
67. Kotevoglu N, Iybozkurt PC, Hz O, Toktas H, Kuran B. A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheumatology International 2005;4.
68. Lanzer WL, Schuster R. A randomized, single-blind comparison of the efficacy and safety of Synvisc Hylan G-F 20 and Aristospan Triamcinolone Hexacetonide in patients with osteoarthritis (OA) of the knee. American Academy of Orthopaedic Surgeons Annual Meeting. Dallas, Texas: AAOS, February 13-17, 2002:Paper No. 135.
69. Leardini G, Franceschini M, Mattara L, Bruno R, Perbellini A. Intra-articular sodium hyaluronate (Hyalgan) in gonarthrosis. A controlled study comparing methylprednisolone acetate. Clinical Trials Journal 1987;24(4):341-50.
70. Leardini G, Mattara L, Franceschini M, Perbellini A. Intra-articular treatment of knee osteoarthritis. A comparative study between hyaluronic acid and 6-methyl prednisolone acetate. Clinical and Experimental Rheumatology 1991;9:375-81.
71. Leopold SS, Redd BB, Warme WJ, Wehrle PA, Pettis PD, Shott S. Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomized trial. The Journal of Bone and Joint Surgery 2003;85-A(7):1197-203.
72. Lin C-C, Tsai C-L, Lee C-H, Chang C-C, Chen S-C, Lai C-H, Beinat L. Efficacy and safety of intra-articular injections of sodium hyaluronate (Hyalgan) in the treatment of osteoarthritis of the knee. A randomized, controlled trial. The Journal of Bone and Joint Surgery in Preparation.
73. Listrat V, Ayral X, Patarnello F, Bonvarlet JP, Simonnet J, Amor B, Dougados M. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis and Cartilage 1997;5:153-60.
74. Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K, et al.Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Annals of the Rheumatic Diseases 1996;55:424-31.
75. McDonald C, Hantel S, Strohmeier M. A randomised, controlled study to compare the performance and safety of two sources of sodium hyaluronate given as a viscosupplement by intra-articular injection to patients with osteoarthritis of the knee. Journal of Clinical Research 2000;3:41-50.
76. Miltner O, Schneider U, Siebert CH, Niedhart C, Niethard FU. Efficacy of intrarticular hyaluronic acid in patients with osteoarthritis - a prospective clinical trial. Osteoarthritis and Cartilage 2002;10(9):680-6.
77. Moreland LW, Arnold WJ, Saway A, Savory C, Sikes D. Efficacy and safety of intra-articular hylan G-F 20 (Synvisc), a viscoelastic derivative of hyaluronan, in patients with osteoarthritis of the knee. Arthritis & Rheumatism 1993;36 Suppl (9):165.
78. Nahler von G, Metelmann H, Sperber H. Treatment of gonarthrosis with Zeel comp. - Results of a randomised, controlled, comparative clinical trial with hyaluronic acid [Behandlung der Gonarthrose mit Zeel comp. - Ergebnisse einer randomisierten, kontrollierten klinischen Prufung im Vergleich zu Hyaluronsaure]. Orthopadische Praxis 1996;32(5):354-9.
79. Nahler G, Metelmann H, Sperber H. Treating osteoarthritis of the knee with a homeopathic preparation. Results of a randomized, controlled, clinical trial in comparison to hyaluronic acid. Biomedical Therapy 1998;XVI(2):186-91.
80. Neustadt D, Wade J, Gimbel J, Bell M, Caldwell J. Clinical effects of intra-articular high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee. Arthritis & Rheumatism 2004;50 Suppl (9):144.
81. Neustadt DH, Caldwell JR, Burnette MC, Block JA, Bhirangi K, Lavin PT, Broderick JN. Intra-articular high molecular weight hyaluronan (Orthovisc) is effective in the treatment of pain of knee osteoarthritis. Annals of the Rheumatic Diseases 2005;64(Suppl III):EULAR, June 8-11, Vienna, Austria.
82. Neustadt D, Caldwell J, Bell M, Wade J, Gimbel J. Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled multicenter trial. The Journal of Rheumatology 2005;32(10):1928-36.
83. Ozturk C, Atamaz F, Hepguler S, Argin M, Arkun R. The safety and efficacy of intraarticular hyaluronan with/without corticosteroid in knee osteoarthritis: 1-year, single-blind, randomized study. Rheumatology International 2005 February 10;Epub ahead of print.
84. Petrella RJ, DiSilvestro MD, Hildebrand C. Effect of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee. A randomized, double-blind, placebo-controlled clinical trial. Archives of Internal Medicine 2002;162:292-8.
85. Pham T, Le Henanff A, Ravaud P, Dieppe P, Brin S, Paolozzi L, Dougados M. Lack of symptomatic and structural efficacy of a new hyaluronic acid (HA) compund (NRD101) when compared to diacerein and placebo in a one-year controlled study in symptomatic knee osteoarthritis. Arthritis & Rheumatism 2003;48 Suppl (9):698.
86. Pham T, Le Henanff A, Ravaud Ph, Dieppe P, Paolozzi L, Dougados M. Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis. Annals of the Rheumatic Diseases 2004;63:1611-7.
87. Pietrogrande V, Melanotte PL, D'Agnolo B, Ulivi M, Benigni GA, Turchetto L, Pierfederici P, Perbellini A. Hyaluronic acid versus methylprednisolone intra-articularly injected for treatment of osteoarthritis of the knee. Current Therapeutic Research 1991;50(5):691-701.
88. Puhl W, Bernau A, Greiling H, Kopcke W, Pforringer W, Steck KJ, Zacher J, Scharf HP. Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthritis and Cartilage 1993;1:233-41.
89. Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, Schultz M, Bellamy N. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis and Cartilage 2002;10(7):506-17.
90. Redd BB, Leopold SS, Warme WJ, Pettis PD, Wehrle PA, Shott S. Corticosteroid vs. Synvisc injections for knee arthritis: a randomized, controlled trial demonstrating similar overall efficacy but significant gender-related treatment differences. American Academy of Orthopaedic Surgeons. New Orleans: AAOS, Feb.5-9, 2003.
91. Rejaili WA, Chueire AG, Cordeiro JA, Petean FC, De Carvalho Filho G. The evaluation of hilan GF-20 in the postoperative knee arthroscopies for arthrosis. Acta Ortop Bras 2005;13(1):20-3.
92. Roman JA, Chismol J, Morales M, Donderis JL. Intra-articular treatment with hyaluronic acid. Comparative study of hyalgan and adant. Clinical Rheumatology 2000;19:204-6.
93. Scale D, Wobig M, Wolpert W. Viscosupplementation of osteoarthritic knees with hylan: a treatment schedule study. Current Therapeutic Research 1994;55(3):220-32.
94. Scale D, Wobig M, Wolpert W. Viscosupplementation of osteoarthritis knees with hylan: a treatment schedule study. Current Therapeutic Research 1994;55(3):220-32.
95. Schneider U, Miltner O, Graf J, Thomsen M, Niethard FU. The efficacy of hyaluronic acid in patients with osteoarthritis of both knees in right/left-comparison - examination with dynamometry, synovial oxygen partial pressure, intraarticular temperature and Lequesne score [Wirkungsweise von Hyaluronsaure bei Gonarthrose beider Kniegelenke im Rechts/Links-Vergleich. Untersuchung mit Dynamometrie, Sauerstoffpartialdruck, Temperatur und Lequesne score]. Zeitschrift Orthop 1997;135:341-7.
96. Sezgin M, Demirel AC, Karaca C, Ortancil O, Ulkar GB, Kamk A, Cakci A. Does hyaluronan affect inflammatory cytokines in knee osteoarthritis?. Rheumatology International 2005;25(4):264-9.
97. Shichikawa K. Evaluation of the effect of sodium hyaluronate (SPH) to osteoarthritis of the knee. The Ryumachi 1983;23(4):280-90.
98. Shichikawa K, Igarashi M, Sugawara S, Iwasaki Y. Clinical evaluation of high molecular weight sodium hyaluronate (SPH) on osteoarthritis of the knee - a mutli-center well controlled comparative study. Japanese Journal of Clinical Pharmacology and Therapeutics 1983;14(3):545-58.
99. St. J. Dixon A, Jacoby RK, Berry H, Hamilton EBD. Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Current Medical Research and Opinion 1988;11(4):205-13.
100. Tamir E, Robinson D, Koren R, Agar G, Halperin N. Intra-articular hyaluronan injections for the treatment of osteoarthritis of the knee: a randomized, double blind, placebo controlled study. Clinical and Experimental Rheumatology 2001;19:265-70.
101. Tascioglu F, Oner C. Efficacy of intra-articular sodium hyaluroante in the treatment of knee osteoarthritis. Clinical Rheumatology 2003;22:112-7.
102. Tekeoglu I, Adak B, Goksoy T, Tosun N. Effects of intra-articular injections of sodium hyaluronate (Orthovisc) and betamethasone on osteoarthritis of the knee. The Journal of Rheumatology & Medical Rehabilitation 1998;9(4):220-4.
103. Thompson JI, Huang YW, Zaibel R. Safety and efficacy of fermentation-derived high molecular weight sodium hyaluronate - a clinical trial in patients with osteoarthritis of the knee. Osteoarthritis and Cartilage 2002;10 Suppl (A):70-1.
104. Tsai C-L, Chang C-C, Chen S-C, Beinat L, Piva S. Treatment of knee osteoarthritis in Asian population with an intra-articular hyaluronan of MW 500-730 KDa. Osteoarthritis and Cartilage 2003;11 Suppl (A):119. [: OARSI October 2003 Berlin].
105. Tsukamoto Y, Yamamoto M, Motegi M, Iwata H, Ryu J, Takagishi K, Sugawara S. A double-blind trial of intra-articular higher molecular weight hyaluronic acid (NRD 101) versus lower molecular weight hyaluronic acid (Artz) in knee osteoarthritis. Rheumatology in Europe 1995;24(EULAR, Amsterdam):333.
106. Wobig M, Dickhut A, Maier R, Vetter G. Viscosupplementation with hyaln G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clinical Therapeutics 1998;20(3):410-23.
107. Wobig M, Bach G, Beks P, Dickhut A, Runzheimer J, Schwieger G, Vetter G, Balazs E. The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clinical Therapeutics 1999;21(9):1549-62.
108. See Wobig 1999.
109. See Wobig 1999.
110. See Wobig 1999.
111. Wu JJ, Shih LY, Hsu HC, Chen TH. The double-blind test of sodium hyaluronate (Artz) on osteoarthritis knee. Chinese Medical Journal (Taipei) 1997;59:99-106.
112. Wu H-B, Du J-Y, Yang S-H, Shao Z-W, Xiong X-Q. Evaluation on the effects of hyaluronan combined with different dosages of celecoxib for relieving pain and ankylosis induced by knee osteoarthritis. Chinese Journal of Clinical Rehabilitation [Zhongguo lin Chuang Kang fu] 2004;8(26):5491-3.
113. Yamamoto M, Sugawara Y, Tsukamoto Y, Motegi M, Iwata H, Rye J, Takagishi K, Nakashima M. Clinical evaluation of high molecular weight sodium hyaluronate (NRD 101) on osteoarthritis of the knee. A phase III comparative clinical study with Artz as a control drug. Japanese Pharmacology & Therapeutics 1994;22(9):4059-87.
114. Yentur EA, Okcu G, Yegul I. The role of trigger point therapy in knee osteoarthritis. The Pain Clinic 2003;15(4):385-90.
115. Aglas F, Hermann J, Uitz E, Rainer F. Long-term benefits of a single treatment cycle with hyaluronan (Hyalgan) in patients with osteoarthritis of the knee. Rheumatology in Europe 1997;26 Suppl (2):46.
116. Akermark C, Berg P, Bjorkman A, Malm P. Non-animal stabilised hyaluronic acid in the treatment of osteoarthritis of the knee. A tolerability study. Clinical Drug Investigation 2002;22(3):157-66.
117. Akermark C, Adalberth T, Ericsater J, Isacsson J. [Patient-perceived efficacy of non-animal stabilized hyaluronic acid in the treatment of osteoarthritis of the knee]. Osteoarthritis and Cartilage 2004;12 Suppl (2):147.
118. Alonge TO, Akinpelu A, Ogunlade SO, Akinosun OM. [Intra-articular Synject in the management of knee OA in Nigeria - an intial report]. Osteoarthritis and Cartilage 2004;12 Suppl (2):148.
119. Angel K, Campbell D, Dobson P, Lewis P, Nisyrios G, Tandon S. [Does viscosupplementation work? A preliminary study]. The Journal of Bone and Joint Surgery 2001;83-B(Suppl III):324.
120. Arizono T, Hara T, Hara Y. Effect of high-molecular-weight sodium hyaluronate on osteoarthrosis. Orthop Surg Traumatol 1997;46 Suppl (1):207-10.
121. Ates A, Kinikli G, Turgay M, Duman M. Viscosupplementation with sodium hyaluronate for the treatment of osteoarthritis. The Journal of Rheumatology 2001;28 Suppl (63):8.
122. Bagga H, Burkhardt D, Morris D, Ghosh P, Sambrook P, March L. [Long term effects of intra-articular hylan G-F 20 (Synvisc) on synovial fluid hyaluronan and sulfated glycosaminoglycans levels]. Annals of the Rheumatic DIseases 2003;EULAR, Lisbon, Portugal, June 18-21.
123. Bardin T, Kieffer P, Hassaynia K, Vincent P, Vincent Aubrey F. [A large study phase IV of intraarticular arthrum H in knee OA patients]. Osteoarthritis and Cartilage 2004;12 Suppl (2):145.
124. Barrett JP, Siviero P. [Retrospective study of outcomes in Hyalgan-treated patients with osteoarthritis of the knee]. Clinical Drug Investigation 2002;23:87-97.
125. Bell M, Fallaha M, Lenczner E, Ranger P, Welsh P. Viscosupplementation with hylan G-F 20 in total knee replacement candidates: an effective pain management therapy that may delay surgery. Osteoarthritis and Cartilage 1999;7 Suppl (A):30.
126. Bellamy N, Goldstein LD, Tekanoff RA. Continuing medical education-driven skills acquisition and impact on improved patient outcomes in family practice setting. The Journal of Continuing Education in the Health Professions 2000;20:52-61.
127. Birbara CA, Bell M, Caldwell JR. [Effectiveness and safety of retreatment with high molecular weight hyaluronan (HMWH; Orthovisc): results from an extension of a randomized controlled trial]. Osteoarthritis and Cartilage 2004;12 Suppl (2):127.
128. Bolgen CImen O, Gulaldi NCM, Ozisik S, Bagis S, Kanik A, Erdogan C. [Clinical and scintigraphic evaluation in intra-articular hyaluronate therapy]. Annals of the Rheumatic Diseases 2003;EULAR, Lisbon, Portugal, June 18-2.
129. Bruce B, Singh G, Sato R, Waddell DD. [Hylan G-F 20 significantly improves pain, function and patient global after 6 months in knee OA]. American Academy of Orthopaedic Surgeons (AAOS) On-Line Service 2004;Annual Meeting Podium Presentations(71st Annual Meeting, March 10-14, San Francisco).
130. Carrabba M, Paresce E, Angelini M, Zamboni AM, Bragantini A, Paissan A, Molinaroli F, Perbellini A. The intra-articular treatment of osteoarthritis of the knee. A comparative study between hyaluronic acid (Hyalgan) and Orgotein. European Journal of Rheumatology and Inflammation 1992;12:47-57.
131. Chhabra SR, Newlove R, Montgomery S. Intraarticular hylan injections in the treatment of osteoarthritis of the knee: a prospective study of 120 patients. The Journal of Bone and Joint Surgery 2000;82-B Suppl (I):68.
132. Clarke S, Lock V, Duddy J, Newman J, Kirwan JR. Intra-articular hylan GF20 (Synvisc) in the management of patellofemoral osteoarthritis of the knee (POAK). Annals of the Rheumatic Diseases 2001;60:230-1.
133. Clarke S, Lock V, Duddy J, Sharif M, Newman JH, Kirwan JR. [Intra-articular hylan G-F 20 (Synvisc) in the management of patellofemoral osteoarthritis of the knee (POAK)]. The Knee 2005;12:57-62.
134. Conrozier T, Mathieu P, Schott A-M, Laurent I, Hajri T, Crozes P, et al Meignan F, Noel E, Rozand Y, Savoye J-F, Vignon E. Is there predictive factors of long term efficacy of viscosupplementation with hylan GF-20 in knee osteoarthritis? [Existe-t-il des facteurs predictifs de l'efficacite a long terme de la viscosupplementation par hylane GF-20 dans la gonarthrose?]. Revue du rhumatisme 2003;70:253-8.
135. Couceiro JM, Coton F, Fernandez A, Collado A, Usabiaga J, Coronel P, Llorens MA and the Adant Study Group. Multicenter clinical trial on the efficacy of intra-articular hyaluronic acid (Adant) in osteoarthritis of the knee [Estudio multicentrico de la eficacia del tratamiento intraarticular con acido hialuronico (Adant) en artrosis de rodilla]. Revista Espanola de Reumatologia 2003;320(2):57-65.
136. D'Agnolo B, Perbellini A. Intra-articular hyaluronic acid treatment in gonarthritis. Results of an open trial on 30 patients. Reumatismo 1988;40:57-64.
137. Dahlberg L, Lohmander LS, Ryd L. Intraarticular injections of hyaluronan in patients with cartilage abnormalities and knee pain. A one-year double-blind, placebo-controlled study. Arthritis & Rheumatism 1994;37(4):521-8.
138. Evanich JD, Evanich CJ, Wright MB, Rydlewicz JA. [Effficacy of intraarticular hyaluronic acid injections in knee osteoarthritis]. Clinical Orthopaedics and Related Research 2001, (390):173-81.
139. Faraawi R. [Retrospective study in intra-articular injection with hylan G-F 20 (patient perspective)]. The Journal of Rheumatology 2003;30(8):1880.
140. Faus S, Fiter J, Canellas. Ultrasound measuring of the thickness of articular cartilage in patients with severe knee osteoarthritis treated with hyaluronic acid. Annals of the Rheumatic Diseases 2002;61 Suppl.
141. Frizziero L, Focherini MC, Govoni E. Hyaluronic acid versus methylprednisolone intra-articular treatment in knee osteoarthritis: a comparative, integrated in vivo and ex vivo morphological assessment by arthroscopy and histopathology. Revista Espanola de Rheumatologia 1993;20 Suppl (1):575.
142. Frizziero L, Pasquali Ronchetti I, Guerra D, Guidolin D. Intra-articular treatment with hyalonic acid: a clinical endoscopic and histological study in osteoarthritis of the knee. Rheumatology in Europe 1997;26 Suppl (2):47.
143. Frizziero L, Govoni E, Bacchini P. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clinical and Experimental Rheumatology 1998;16:441-9.
144. Fuji T, Matsui S, Fujita S, Hirota S. Clinical effect of intra-articular injection of sodium hyaluronate (Artz) on osteoarthritis of the knee. A study comparing between independently using and combined using local anesthetic. Japanese Journal of Medicine and Pharmaceutical Sciences 1994;32(3):507-13.
145. Goorman SD, Watanabe TK, Miller EH, Perry C. Functional outcome in knee osteoarthritis after treatment with hylan G-F 20: a prospective study. Archives of Physical Medicine and Rehabilitation 2000;81:479-83.
146. Grecomoro G, Piccione F, Letizia G. Therapeutic synergism between hyaluronic acid and dexamethasone in the intra-articular treatment of osteoarthritis of the knee: a preliminary open study. Current Medical Research and Opinion 1992;13(1):49-55.
147. Guerrero R, Sanchez-Pernaute O, Acebes C, Llorens MA, Mas S, Palacios I, et al.Modification of synovial cartilage markers after repetitive intraarticular administration of hyaluronate (Adant) in knee OA patients. Arthritis & Rheumatism 1999;42 Suppl (9):253.
148. Guerrero R, Herreo-Beaumont G, Acebes C, Sanchez-Pernaute O, Llorens MA, Blazquez AB, Palacios I, Egido J, Vivanco F. Cartilage turnover and symptomatic relief observed in patients with knee OA after intra-articular administration of a hyaluronate polymer (Adant). Osteoarthritis and Cartilage 1999;7 Suppl (A):32.
149. Hamburger MI, Hamburger MK, Brandt L, Kaell AT, Bennett RS, Johnson S, Rumore P, Schulman P. [Retrospective comparative analysis of the safety and efficacy of intra-articular hyaluronan therapies in clinical practice]. Osteoarthritis and Cartilage 2004;12 Suppl (2):146.
150. Hashimoto Y, et al.Multicenter clinical studies of ARTZ (high molecular weight sodium hyaluronate) in the long term treatment of osteoarthritis of the knee: including x-ray analysis. Japanese Pharmacology & Therapeutics 1992;20(7):2699-712.
151. Honma T, Sakurai M, Maeda I, et al.Clinical effects of high molecular weight sodium hyaluronate (Artz) injected into osteoarthritis knee joint. Japanese Pharmacology & Therapeutics 1989;17(10):5057-72.
152. Igarashi M, Onozawa T, Murata M, et al.Multicentre clinical studies of high molecular weight sodium hyaluronate in the long-term treatment of osteoarthritis of the knee. Japanese Pharmacology & Therapeutics 1983;11(11):4871-88.
153. Ines LS, Reis P, Santos MJ, Alexandre M, Silva C, Brana A, Barcelos A, Nour D, Silva JAP, Malcata A, Porto A. Joint lavage and infiltration as treatment for knee arthritis: an open follow-up evaluation in the clinical setting. Annals of the Rheumatic Diseases 2002;61 Suppl.
154. Iseki F, Hosokawa M, Shibata H, et al.Clinical study of high molecular weight sodium hyaluronate (SPH) on osteoarthritis of the knee. Japanese Pharmacology & Therapeutics 1983;11(8):401(3283)-15(97).
155. Iwaskai K, Norimatsu T, Matsuzaka N, Teramoto T. Usefulness of sodium hyaluronate (Artz) in osteoarthritis of the knee. Comparison between monotherapy and combination therapy with a local anesthetic. Medical Consultation & New Remedies 1993;30(8):1469-76.
156. Johnson DM. [Audit of the effect on pain scores of intra-articular hyalgan injection in patients with osteoarthritis of the knee in a nurse-led clinic]. Rheumatology 2004;43(Suppl 2):ii156.
157. Kawakami K, et al.Clinical evaluation of intra-articlar injection therapy of high-molecular Na-hyaluronate for osteoarthritis of the knee joint. Journal of Medicine and Pharmaceutical Science 1993;29(5):1309.
158. Kolarz G, Kotz R, Broll H, Dunky A, Landsiedl F, Mayrhofer F, Rainer F, Ramach W, Singer F, Metz M. [Hyaluronic acid in the treatment of osteoarthritis of the knee joint: interim results of a comparative clinical study]. European Journal of Rheumatology and Inflammation 1995;15(1):39-46.
159. Kolarz G, Kotz R, Hochmayer I. [Long-term benefits and repeated treatment cycles of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee]. Seminars in Arthritis and Rheumatism 2003;32(5):310-9.
160. Kotz R, Kolarz G. Intra-articular hyaluronic acid: duration of effect and results of repeated treatment cycles. American Journal of Orthopedics 1999;28 Suppl (11):5-7.
161. Koyuncu H, Dinc A, Ozkul Y, Yucel E. Clinical, functional and radiological efficacy and tolerability of hyaluronate in osteoarthritis - an open study. Annals of the Rheumatic Diseases 2002;61 Suppl (EULAR).
162. Koyuncu H, Uludag M, Cakmak B, Yucel E, Dinc A, Toros H. [The efficacy and safety of viscosupplementation with hylan G-F 20 in osteoarthritic knee]. Osteoarthritis and Cartilage 2003;11 Suppl (A):45.
163. Kumar N, Rao C, Marshall NJ, Griffiths ID. [Results of one year follow up after treatment with viscosupplementation]. Annals of the Rheumatic Diseases 2003;EULAR, Lisbon, Portugal, June 18-21.
164. Kurokawa T, et al.Clinical evaluation of high molecular weight sodium hyaluronate (NRD101) on osteoarthritis of the knee: phase III long-term clinical study. Jpn Pharmacol Ther 1994;22(9):4007-28.
165. Lee S-S, Joo Y-S, Kim W-U, Park S-H, Cho C-S, Kim H-Y, Kim H-J, Kim S-J. Clinical efficacy and safety of hyruan (sodium hyaluronate) in patients with osteoarthritis of the knee. J Korean Rheum Assoc 1999;6(1):53-61.
166. Lee S, Park D, Chmell SJ. Viscosupplementation with hylan G-F 20 (Synvisc). The Journal of Knee Surgery 2004;17(2):73-7.
167. Legre V, Pham T, Lafforgue P. Evaluation of safety and efficacy of hylan GF-20 in knee osteoarthritis with chondrocalcinosis. Osteoarthritis and Cartilage 2001;9 Suppl (B):47.
168. Leopold SS, Warme WJ, Pettis PD, Shott S. [Increased frequency of acute local reaction to intra-articular hylan GF-20 (Synvisc) in patients receiving more than one course of treatment]. The Journal of Bone and Joint Surgery 2002;83-A(9):1619-23.
169. Lussier A, Cividino AA, McFarlane CA, Olszynski WP, Potashner WJ, De Medicis R. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. The Journal of Rheumatology 1996;23(9):1579-85.
170. Magobotha SK, Rogan IM. [Viscosupplementation: an alternative method of treating osteoarthritis of the knee]. The Journal of Bone and Joint Surgery 2001;83-B Suppl (1):10-1.
171. Mathieu P, Conrozier T, Schott AM, Laurent I, Marc JF, Vignon E. [Viscosupplementation with hylan GF-20 in knee osteoarthritis: assessment of the predictive factors of long-term efficacy]. Osteoarthritis and Cartilge 2001;9 Suppl (B):27.
172. Mazieres B, Bacri A, Bard H, Le Pen C, Riviere M. [French pharmacoeconomic study of hyaluronic acid for osteoarthritis of the knee. An interim analysis]. Annals of the Rheumatic Diseases 2004;EULAR, Berlin, June 9-12.
173. Mazzocato G, Melanotte PL, Perbellini A. [Efficacia terapeutica dello ialuronato di sodio nell-arthrosi del ginocchio. Risultati di uno studio in aperto]. Ortopedia e traumatologia oggi 1987;VII(6):333-8.
174. Megyeri A, Genti G. [Intra-articular treatment with sodium hyaluronate in osteoarthritis of the knee: short-term clinical study]. Revista Espanola de Reumatologia 1993;20 Suppl (1):329.
175. Mensitieri M, Ambrosio L, Iannace S, Nicolais L. Viscoelastic evaluation of different knee osteoarthritis therapies. Journal of Materials Science: Materials in Medicine 1995;6:130-7.
176. Milini C, Monini L, Brunelli G. Hyaluronic acid in the treatment of gonarthrosis. Findings of an open study [L'acido ialuronico nel trattamento della gonartrosi. Risultati di uno studio in aperto]. Farmaci 1989;13:1-7.
177. Miller EH, Snyder MA, Heidt RS, Welch MC. Analysis of the results of viscosupplementation with hylan G-F 20 in the treatment of osteoarthritis of the knee: a prospective study of 108 patients. 66th Annual Meeting Proceedings, American Academy of Orthopaedic Surgeons. Anaheim, CA, February 4-8, 1999:233.
178. Minami S, Okazaki, T, Tanaka T, Isobe K, Tsuchida T, Saegusa O, Fujitsuka M, Moriya H. A study of the effect of intra-articular injection of SLM-10 (sodium hyaluronate) on osteoarthritis of the knee. Japanese Pharmacology & Therapeutics 1993;21 Suppl (2):565-79.
179. Moller I, Moragues C, Marti N, Alegre JJ. [Intra-articular hyaluronate efficacy and safety in treatment of knee OA]. Osteoarthritis and Cartilage 2001;9 Suppl (B):51.
180. Monfort J, Benito P. [Treatment with hyaluronic acid in patients affected with gonarthrosis with and without chondrocalcinosis]. Osteoarthritis and Cartilage 2000;8 Suppl (B):70.
181. Myburgh JG. [Viscosupplementation with hylan G-F 20 in the treatment of osteoarthritis]. The Journal of Bone and Joint Surgery 2001;83-B Suppl (1):10.
182. Namiki O, Toyoshima H, Morisaki N. Therapeutic effect of intra-articular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee. International Journal of Clinical Pharmacology, Therapy and Toxicology 1982;20(11):501-7.
183. Neustadt DH. [Clinical experience with intra-articular hyaluronate in osteoarthritis of the knee]. The Journal of Rheumatology 2001;28 Suppl (63):6.
184. Neustadt DH. [Long-term efficacy and safety of intra-articular sodium hyaluroante (Hyalgan) in patients with osteoarthritis of the knee]. Clinical and Experimental Rheumatology 2003;21:307-11.
185. Novaes AC, Schaiquevich P, Nasswetter G, The Latin American Group of Quality of Life in Rheumatology. [Multicenter study of hyaluronic acid obtained by biotechnology to evaluate clinical efficacy and safety in knee osteoarthritis]. International Journal of Clinical and Pharmacology Research 2005;XXV(1):1-7.
186. Oberoi IS. [Gains of viscosupplementation following arthroscopic assisted surgery in gonarthrosis in femoro-tibial joints]. International Cartilage Repair Society, 5th Symposium. Gent, Belgium, May 26-29, 2004:20-1.
187. Olszynski WP, Olszynski M. The effect of viscosupplementation therapy among patients suffering from degenerative joint disease of the knees. The Journal of Rheumatology 2002;29(7):1572.
188. Ono K, Nakahara H, Yonenobu K, Ochi T, Hongo I, Mizushima T, et al.[A study of the effect of intra-articular injection of high molecular weight sodium hyaluronate (SLM-10) on osteoarthritis of the knee joint]. Japanese Pharmacology & Therapeutics 1993;21 Suppl (2):611-32.
189. Ono K, Hirasawa Y, Matsui N, Moriya H. [A study of the effect of intra-articular long term injection of high molecular weight sodium hyaluronate (SLM-10) on osteoarthritis of the knee joint]. Japanese Pharmacology & Therapeutics 1993;21 Suppl (2):687-702.
190. Oron A, Mirovsky Y, Agar G, Halperin N. [Viscosupplementation with Orthovisc vs. Synvisc for the treatment of osteoarthritis: findings from clinical practice in Israel]. Osteoarthritis and Cartilage 2003;11 Suppl (A):46.
191. Oshima Y, Azuma H, Namiki O, Aoki T, Azuma T, Irie N, et al.Intra-articular injection therapy of high molecular weight sodium hyaluronate (SPH) on osteoarthritis of the knee joint - phase II clinical study. Japanese Pharmacology & Therapeutics 1983;11(6):2253-67.
192. Pasquali Ronchetti I, Guerra D, Taparelli F, Boraldi F, Bergamini G, Mori G, Zizzi F, Frizziero L. [Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinial study comparing the effects of sodium hyaluronate (HyalganR) and methylprednisolone acetate (DepomedrolR) in osteoarthritis]. Rheumatology 2001;40:158-69.
193. Pavelka K. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: findings from clinical practise in Czech Republic. Annals of the Rheumatic Diseases 2002;61 Suppl.
194. Pavelka K. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: findings from clinical practise in Czech Republic. Czech Acta Chir Orthop Traumatol Cech 2002;69:302-7.
195. Payne MW, Petrella RJ. [Viscosupplementation effect on proprioception in the osteoarthritic knee]. Archives of Physical Medicine and Rehabilitation 2000;81:598-603.
196. Petrella RJ, Cogliano A. [Sodium hyaluronate (Suplasyn) viscosupplementation for treatment of knee osteoarthritis: clinical and functional outcomes and treatment satisfaction from routine clinical practice]. Annals of the Rheumatic Diseases 2003;EULAR, Lisbon, Portugal, June 18-21.
197. Petrella RJ, Riviere M. The utilization of hyaluronic acid for the treatment of osteoarthritis within the primary care experience (methodology of data mining of a large database >53 000). Osteoarthritis and Cartilage. 2003; Vol. 11 Suppl (A):83.
198. Petrella RJ, Cogliano A. [Sodium hyaluronate viscosupplementation for treatment of knee osteoarthritis: clinical and functional outcomes and treatment satisfaction from routine clinical practices]. Osteoarthritis and Cartilage 2003;11 Suppl (A):101.
199. Petrella RJ. Hyaluronic acid for the treatment of knee osteoarthritis: long-term outcomes from a naturalistic primary care experience. American Journal of Physical Medicine & Rehabilitation 2005;84(4):278-83.
200. Pipino F, Molfetta L, Berlingerio G. Hyaluronic acid in the treatment of gonarthrosis. Results of an open trial [L'acido ialuronico nella terapia della gonartrosi]. Minerva Ortopedica e Traumatologica 1990;41(11):655-60.
201. Punzi L, Schiavon F, Ramonda R, Malatesta V, Gambari P, Todesco S. Intra-articular hyaluronic acid in the treatment of inflammatory and noninflammatory knee effusions. Current Therapeutic Research 1988;43(4):643-47.
202. Rao C, Kumar N, Young-Min S, Marshall NJ, Platt PN, Griffiths ID. Experiences with a viscosupplementation (Hyalgan) clinic. Annals of the Rheumatic Diseases 2001;60 Suppl (1):233.
203. Rastogi S, Sharma VK, Chandra R, Sivaraman ST. [Open label multicentre trial on safety and efficacy of intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee - a prospective study]. Journal, Indian Academy of Clinical Medicine 2005;6(3):232-5.
204. Russell IJ, Michalek JE, Lawrence VA, Lessard JA, Briggs BT, May GS. A randomized, placebo (PL) and no-intervention (NI) controlled, trial of intra-articular (IA) 1% sodium hyaluronate (HA) in the treatment of knee osteoarthritis (OA). Arthritis & Rheumatism 1992;35 Suppl:132.
205. Scali JJ. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: a long term study. European Journal of Rheumatology and Inflammation 1995;15(1):57-62.
206. Sepici V, Sepici A, Acikgoz S, Tali T. The role of viscosupplementation with sodium hyaluronate (Orthovisc) in urine gag levels and magnetic resonance imaging (MRI) features of osteoarthritis of the knee. Annals of the Rheumatic Diseases 2002;61 Suppl.
207. Shibata S. Using experience and significance of sodium hyaluronate (Artz) for osteoarthritis of the knee. Journal of New Remedies & Clinics 1993;42(3):598.
208. Sieliwonczyk P, Mazurkiewicz S, Ostojski R, Kusiak A. The value of intraarticular Hyalgan injections in treatment of osteoarthritis of the knee [Ocena wartosci dostawowych iniekcji preparatu Hyalgan w leczeniu zmian zwyrodnieniowych stawu kolanowego]. Chir Narz Ruchu Ortop Pol 1997;LXIII(4):337-42.
209. Singh G, Bruce B, Sato R, Waddell DD. [Treatment satisfaction in patients treated with hylan G-F 20 vs. intra-articular steroids at 6 months]. American Academy of Orthopaedic Surgeons (AAOS) On-Line Service 2004;Annual Meeting Podium Presentations(71st Annual Meeting, March 10-14, San Francisco).
210. Sripada P, Pritchard C, Bankes PF. Comparison efficacy of hyaluronan and hylan G-F 20 in osteoarthritis. Arthritis & Rheumatism 1999;42 Suppl (9):296.
211. Stambuk B, Gnjidic Z, Brencic-Dlesk M. [Efficacy and safety of intra-articular injection of hylan GF-20 (Synvisc) for the knee]. The Journal of Rheumatology 2001;28 Suppl (63):10.
212. Suzu F, Hirasawa Y. Results of long term treatment with ARTZ for the knee osteoarthritis. Japanese Pharmacology & Therapeutics 1990;18(12):4979-84.
213. Suzu F, Hirasawa Y. A study of the effect of high molecular weight sodium hyaluronate (SLM-10) on osteoarthritis of the knee joint. Japanese Pharmacology & Therapeutics 1993;21 Suppl (2):595-610.
214. Takeuchi H, Yamaguchi I, Morita S, Kawagoe S, Chosa E, Maehara T, Kuroki T, Kuwahara S. Multicenter clinical study in intraarticular injection of high molecular sodium hyaluronate (ARTZ) for osteoarthritis of the knee. Journal of Medicine and Pharmaceutical Science 1993;29(6):1517-25.
215. Taneda Y, Matsui N, Nakane K, Takai Y, Suzuki H, Hongoh N. A study of the effect of SLM-10 on osteoarthritis of the knee. Japanese Pharmacology & Therapeutics 1993;21 Suppl (2):581-93.
216. Tang SF, Chen CP, Chen MJ, Pei Y-C, Lau Y-C, Leong C-P. [Changes in sagittal ground reaction forces after intra-articular hyaluronate injections for knee osteoarthritis]. Archives Physical Medicine and Rehabilitation 2004;85(6):951-5.
217. Tang SFT, Chen CPC, Chen MJL, Hong WH, Yu TY, Tsai WC. [Improvement of muscle strength in osteoarthritic knee patients after intraarticular knee injection of hyaluronan]. American Journal of Physical Medicine & Rehabilitation 2005;84(4):274-7.
218. Toh EM, Prasad PS, Teanby D. [Correlating the efficacy of knee viscosupplementation with osteoarthritic changes on roentgenological examination]. The Knee 2002;9:321-30.
219. Toh EM, Prasad P, Teanby D. [Correlating the outcome of knee intraarticular viscosupplementation with radiological changes of osteoarthritis]. The Journal of Bone and Joint Surgery 2003;85-B Suppl (II):178.
220. Torrance GW, Raynauld JP, Walker V, Goldsmith CH, Bellamy N, Band PA, Schultz M, Tugwell P. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 2 of 2): economic results. Osteoarthritis and Cartilage 2002;10(7):518-27.
221. Turajane T, Labpiboonpong V, Maungsiri S, Sattayathum P. [Therapeutic effects of intra-articular hyaluronan on failed conservative treatment of knee osteoarthritis with minimum two years follow up]. Annals of the Rheumatic Diseases 2005;64(Suppl III):EULAR, June 8-11, Vienna, Austria.
222. Turajane T, Labpiboonpong V, Maungsiri S, Sattayathum P. [Medico-economic analysis of sodium hyaluronate (Hyalgan) treatment in an Asian population over 65 yrs with Kellgren-Lawrence grade 4 knee OA who failed conservative treatment]. Annals of the Rheumatic Diseases 2005;64(Suppl III):EULAR, June 8-11, Vienna, Austria.
223. Uebelhart D, Berz S. [Safety and efficacy of fermentative hyaluronan in knee osteoarthritis: a retrospective study]. Osteoarthritis and Cartilage 2003;11 Suppl (A):80.
224. Vad VB, Cooke PM, Wickiewicz TL, Sculco TP, Warren RF, Althek DW. Hylan versus knee lavage and hylan in management of knee osteoarthritis. 67th Annual Meeting Proceedings, American Academy of Orthopedic Surgeons. Orlando, FL, March 15-19, 2000:456.
225. Vad VB, Bhat AL, Sculco TP, Wickiewicz TL. [Management of knee osteoarthritis: knee lavage combined with hylan versus hylan alone]. Archives of Physical Medicine and Rehabilitation 2003;84:634-7.
226. Waddell DD, Estey DJ, Bricker D. [Retrospective tolerance of hylan G-F 20 using fluoroscopically-confirmed injection and effectiveness of retreatment of knee osteoarthritis]. Arthritis & Rheumatism 2001;44 Suppl (9):48.
227. Waddell DD, Bricker D. [Hylan G-F 20 reduces the probability of progression to total knee replacement in knee osteoarthritis]. Arthritis & Rheumatism 2001;44 Suppl (9):49.
228. Waddell D, Rein A, Panarites C, Coleman PM, Weiss C. [Cost implications of introducing an alternative treatment for patients with osteoarthritis of the knee in a managed care setting]. American Journal of Management and Care 2001;7(10):981-91.
229. Waddell DD, Cefalu CA, Bricker DC. [A 52-week, open-label study of a second course of hylan G-F 20 for the treatment of pain associated with osteoarthritis of the knee]. Annals of the Rheumatic Diseases 2003;EULAR, Lisbon, Portugal, June 18-21.
230. Waddell DD, Bricker DC. [Hylan G-F 20 reduces the probability of progression to total knee replacement in knee osteoarthritis]. Annals of the Rheumatic Diseases 2003;EULAR, Lisbon, Portugal, June 18-21.
231. Waddell DD, Bricker DC. [Hylan G-F 20 in knee osteoarthritis patients: low incidence and clinical management of local adverse events]. Arthritis & Rheumatism. 2003; Vol. 48 Suppl (9):486.
232. Waddell DD, Cefalu CA, Bricker DC. [An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis]. Current Medical Research and Opinion 2003;19(6):499-507.
233. Weiss C, Tillero W, Balazs L. The treatment of osteoarthritis of the knee with hylan GF20 in orthopaedic practice. Osteoarthritis and Cartilage 1999;7 Suppl (A):37.
234. Wobig M, Beks P, Dickhut A, Maier R, Vetter. Open-label multicenter trial of the safety and efficacy of viscosupplementation with hylan G-F20 (Synvisc) in primary osteoarthritis of the knee. Journal of Clinical Rheumatology 1999;5 Suppl (6):24-31.
235. Wulwik A, Bertocci S, Raude-Leroy V, Lleu PL. [Efficacy and safety of Synvisc in severe knee osteoarthritis (OA): experience from a large cohort of patients followed in private rheumatological practice]. Annals of the Rheumatic Diseases 2001;60 Suppl (I):226.
236. Yoh K, Tsuji H, Maruoka T, Tateishi H. Clinical results of intra-articular treatment with sodium hyaluronate in osteoarthritis of the knee. Clinical Rheumatology 1989;2(2):132-6.
237. Zamora-Quezada J. [Clinical practice adoption of a Touch-Screen Outcome Patient Surveys (TOPS) in the management of chronic pain of osteoarthriis]. Arthritis and Rheumatism 2004;50(9(Suppl)):S468-9.
238. Anand S, Mitchell S, Bamforth C, Asumu T, Buch KA. [Effect of intra-articular injection of sodum hyaluronate on recovery after arthroscopic knee surgery]. Osteoarthritis and Cartilage 2004;12 Suppl (2):141.
239. Blanco Garcia FJ, Fernandez Sueiro JL, Pinto JA, Fernandez Lopez JC, Ramos M, Gimeno M, Coronel P, Galdo F. [Treating of patients with knee osteoarthritis waiting by replacement surgery with intra-articular hyaluronic acid (Adant)]. Osteoarthritis and Cartilage 2004;12 Suppl (2):142-3.
240. Soenarwo Briliantono M. [Treatment of osteoarthritis of the knee by intra-articular hyaluronic acid]. Immunology and Cell Biology 1996;74:A16.
241. Caracuel MA, Munoz-Villanueva MC, Escudero A, Veroz R, Frias G, Vacas J, et al.[Effects of joint lavage and hyaluronic acid infiltration in patients with osteoarthritis of the knee]. Annals of the Rheumatic Diseases 2001;60 Suppl (I):236-7.
242. Castro C, Font P, Munoz E, Frias G, Caracuel MA, Vacas J, Perez V, Escudero A, Lopez P, Collantes E. Efficacy and safety of intra-articular hyaluronic acid compared (HA) to steroid injections in patients with knee osteoarthritis. Annals of the Rheumatic Diseases 2005;64(Suppl III):EULAR, June 8-11, Austria, Vienna.
243. Garcia B. [A comparative study: adverse reactions to Synvisc(R) but not Hyalgan(R)]. American Academy of Orthopaedic Surgeons (AAOS) On-Line Service 2004;71st Annual Meeting, March 10-14, San Francisco(Annual Meeting Poster Presentations).
244. Gur A, Kylync S, Sarac AJ, Nas K, Cevik R. Effects of intra-articular hyaluronic acid and corticosteroid in the patients with serious knee osteoarthritis. Annals of the Rheumatic Diseases 2002;61 Suppl (EULAR).
245. Joergensen A, Stengaard-Pedersen K. [Hyaluronan intra-articular is without clinical effect in knee osteoarthritis (OA). A multicentre, randomised, placebo controlled, double-blind study]. Annals of the Rheumatic Diseases 2005;64(Suppl III):EULAR, June 8-11, Vienna, Austria.
246. Kilinc S, Gur A, Sarac AJ, Nas K, Cevik R. Comparison of intra-articular hyaluronic acid and physiotherapy in the management of serious knee osteoarthritis. Annals of the Rheumatic Diseases 2002;61 Suppl (EULAR).
247. Kim SB, Yoon K, Park HS, Kwak H, Ha NJ, Park JS. The effect of intra-articular hyaluronic acid and steroid injection in osteoarthritis of the knee. Journal of the Korean Academy of Rehabilition Medicine 2000;24(4):747-55.
248. Koyunci H, Kinc A, Ozkul Y, Yucel E. Clinical, functional and radiological efficacy and tolerability of hyaluronate in osteoarthritis - an open study. Annals of the Rheumatic Diseases 2002;61 Suppl (EULAR).
249. Kuzmanova SI, Solakov PT. [Sodium hyaluronate 500-730 KDA (Hyalgan) intra-articularly after treatment of synovitis in primary active osteoarthritis of the knee joint with betamethasone]. Annals of the Rheumatic Diseases 2005;64(Suppl III):EULAR, June 8-11, Vienna, Austria.
250. Lee DC, Beak SH, Sohn WJ, Shin KS, Han JH. Effect of the hyaluronic acid on osteoarthritis of the knee. Journal of the Korean Knee Society 2002;14(2):213-21.
251. Lucangeli A, Gugelmetto M, Primon D. Physical therapy and intraarticular hyaluronic acid in the treatment of osteoarthritis [Terapia fisica e acido ialuronico per via intra-articolare nel trattamento della gonartrosi]. Revista Italiana di Biologia e Medicina 2001;21(1-2):5-10.
252. Petrella RJ, Alkemade SJ, Salvatori VA. Sodium hyaluronate for functional improvement of the osteoarthritic knee - three and six injections. Osteoarthritis and Cartilage 2002;10 Suppl (A):71.
253. Renklitepe N, Atalay E. The effect of intra-articular sodium hyaluronate therapy in knee osteoarthritis. Annals of the Rheumatic Diseases 2000;59 Suppl (1).
254. Russell ID, Baker D, Johnson SR. [A comparison of synvisc and arthroscopic lavage in the mangement of osteoarthritis of the knee]. The Journal of Bone and Joint Surgery 2003;85-B Suppl (II):106.
255. Shariati J, Hatef M, Jokar M. Intraarticular Hylan G-F20 (Synvisc) in the treatment of patients with osteoarthritis of the knee. The Journal of Rheumatology 2001;28 Suppl (63):3.
256. Sinha S, Singh BJ, Thilagarajah M, Housden P. [Single vs multiple dose intra-articular hyaluronic acid in patients with osteoarthritis knee - a prospective clinical trial]. Osteoarthritis and Cartilage 2003;11 Suppl (A):43.
257. Stitik TP, Foye PM, Stiskal DM, Nadler SF, Chen B, Schoenherr L. [Intra-articular hyaluronate (MW 500-730 KDA) therapy and concomitant home exercise strengthening: an effective additive therapeutic algorithm for osteoarthritis of the knee]. Osteoarthritis and Cartilage 2004;12 Suppl (2):84.
258. Talwalkar NC, Russell DI, Johnson S. [Management of osteoarthritis of the knee, knee lavage compared with intraarticular hylan G-F 20 (Synvisc) injections]. Journal of the Japanese Orthopaedic Association 2005;79(3):S57.
259. Xu P, Guo X, Jin WZ, Yao J, Zhang Y, Cai Q. Clinical observaion on effect of intra-articular injection of sodium hyaluronate accompanied with external application of sanhua ointment for knee osteoarthritis [[Chinese]]. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi [Chinese Journal of Integrated Traditional & Western Medicine] 2005;25(7):620-2.
260. Za ZG, Song YC, Zao MJ, Liu CF. Comparison of therapeutic results of Danshen and sodium hyaluronate injection for knee osteoarthritis. Chinese Journal of Clinical Rehabilitation 2002;6(24):3746-7.
261. Orthovisc compared to saline: a double-blind, randomised controlled trial. Anika Therapeutics Press Release August 1999.
262. Hempfling H. Long-term outcome of synovial fluid substitution with Viscoseal post-arthroscopy. Osteoarthritis and Cartilage 2003;11 Suppl (A):79.
263. Department of Health, London, UK Phase III trial.
264. Juni P, Villiger PM, Dieppe PA, Zullig M, Egger M for the SVISCOT Group. [Viscosupplementation for osteoarthritis of the knee: protocol for the Swiss viscosupplementation trial (SVISCOT)]. May 15, 2003; Vol. Draft #22.
265. Prospective randomised single blind trial comparing the effectiveness of combined arthroscopic washout and intra articular hyaluronan injection to intra articular hyaluronan injection and arthroscopic washout in isolation, for osteoarthritis of the knee.
266. Sanofi-Aventis Phase IV trial.
267. Genzyme Phase III trial.
268. Genzyme Phase III trial.
269. Glostrup University Hospital, Phase IV trial.
270. Russell ID, Baker D, Johnson SR. A comparison of Synvisc and arthroscopic lavage in the management of osteoarthritis of the knee. The Journal of Bone and Joint Surgery 2001;83-B Suppl (II):213.
271. American College of Rheumatology Subcommittee on osteoarthritis guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee. 2000 Update. Arthritis & Rheumatism 2000;43(9):1905-15.
272. Adams ME, Lussier AJ, Peyron JG. [A risk-benefit assessment of injections of hyaluronan and derivatives in the treatment of osteoarthritis of the knee]. Drug Safety 2000;23(2):115-30.
273. Aggarwal A, Sempowski IP. [Hyaluronic acid injections for knee osteoarthritis. Systematic review of the literature]. Canadian Family Physician 2004;50:249-56.
274. Albert C, Brocq O, Gerard D, Roux C, Euller-Ziegler L. [Septic knee arthritis after intra-articular hyaluronate injection. Two case reports]. Joint Bone Spine 2005.
275. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al.[Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee]. Arthritis & Rheumatism 1986;29(8):1039-49.
276. Altman RD. [Criteria for classification of clinical osteoarthritis]. The Journal of Rheumatology 1991;18 Suppl (27):10-2.
277. Altman RD. Intra-articular sodium hyaluronate in osteoarthritis of the knee. Seminars in Arthritis and Rheumatism 2000;30 Suppl (1):11-8.
278. Altman R, Moskowitz R. [Hyaluronate sodium injections for osteoarthritis: the truth]. Archives of Internal Medicine 2002;162:2498-9.
279. Altman RD. [Status of hyaluronan supplementation therapy in osteoarthritis]. Current Rheumatology Reports 2003;5:7-14. [: ISSN 1523-3774].
280. Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Mullner M. [Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis]. Canadian Medical Association Journal 2005;172(8):1039-1043. [: DOI:10.1503/cmaj.1041203].
281. Aviad AD, Houpt JB. [The molecular weight of therapeutic hyaluronan (sodium hyaluronate): how significant is it?]. The Journal of Rheumatology 1994;21(2):297-301.
282. Ayral X. Injections in the treatment of osteoarthritis. Bailliere's Best Practice & Research in Clinical Rheumatology 2001;15(4):609-26. [: DOI: 10.1053/berh.2001.0177].
283. Bachinger A, Rappenhoner B, Rychlik R. [Zur soziookonomischen Effizienz einer Zeel comp.-Therapie im Vergleich zu Hyaluronsaure bei Patienten mit Gonarthrose]. Zeitschrift fur Orthopadie und ihre Grenzgebiete 1996;134(4):Oa20-1.
284. Balazs EA. [The physical properites of synovial fluid and the special role of hyaluronic acid]. In: Helfet AJ editor(s). Disorders of the Knee. 2. Philadelphia: J. B. Lippincott Company, 1982:61-74.
285. Band PA. Comparing different therapeutic classes for the treatment of osteoarthritis of the knee: data from the OMERACT-OARSI responder criteria analysis. Osteoarthritis and Cartilage 2005.
286. Bell MJ, Bellamy N, Goldsmith CH, Tugwell P, Torrance GW, Raynauld J-P, Polisson R, Pericak D, Walker V. [Evaluation of the OARSI and OMERACT-OARSI set of responder criteria in patients treated with hylan G-F 20 for knee osteoarthritis]. Arthritis & Rheumatism. 2003; Vol. 48 Suppl (9):482.
287. Bellamy N. Musculoskeletal Clinical Metrology. Dordrecht: Kluwer Academic Publishers, 1993.
288. Bellamy N, Kirwan J, Boers M, Brooks P, Strand V, Tugwell P, Altman R, Brandt K, Dougados M, Lequesne M. [Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III]. The Journal of Rheumatology 1997;24(4):799-802.
289. Bellamy N, Campbell J, Hill J, Band P. [A comparative study of telephone versus onsite completion of the WOMAC 3.0 Osteoarthritis Index]. The Journal of Rheumatology 2002;29(4):783-6.
290. Bellamy N, Campbell J, Gee T, Robinson V, Wells G, Bourne RB. [Hylan G-F 20 for knee osteoarthritis (OA): a Cochrane review]. Arthritis & Rheumatism 2003;48 Suppl (9):697.
291. Bellamy N, Bell MJ, Goldsmith CH, Tugwell P, Torrance GW, Raynauld JP, Polisson R, Pericak D, Walker V. [WOMAC 20, 50, 70 response levels in patients treated with hylan G-F 20 for knee osteoarthritis]. Osteoarthritis and Cartilage 2003;11 Suppl (A):82.
292. Bellamy N, Bell MJ, Goldsmith CH, Tugwell P, Torrance GW, Raynauld JP, Polisson R, Pericak D, Walker V. [Symptom free response using the WOMAC pain score in patients treated with hylan G-F 20 for knee osteoarthritis]. Osteoarthritis and Cartilage 2003;11 Suppl (A):42-3.
293. Bellamy N, Bell MJ, Goldsmith CH, Torrance GW, Raynauld J, Tugwell P, Polisson R, Pericak D, Walker V. [Examining minimal perceptible clinical improvement criteria in patients treated with hylan G-F 20 for knee osteoarthritis]. Annals of the Rheumatic Diseases 2004;EULAR, Berlin, June 9-12.
294. Bellamy N, Campbell J, Robinson V, Wells GA, Bourne RB. A Cochrane review of viscosupplementation: hylan G-F 20 versus placebo. Osteoporosis International 2005;16(3):S12.
295. Bellamy N, Bell MJ, Goldsmith CH, Pericak D, Walker V, Raynauld J-P, Torrance GW, Tugwell P, Polisson R. The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT-OARSI. Osteoarthritis and Cartilage 2005;13(2):104-10.
296. Bellamy N, Bell MJ, Goldsmith CH, Pericak D, Walker V, Raynauld JP, TorranceGW, Tugwell P, Polisson R. [Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritis]. Annals of the Rheumatic Diseases 2005;64:881-5.
297. Berstein J. [Therapeutic effects of hyaluronic acid on osteoarthritis of the knee]. The Journal of Bone and Joint Surgery 2004;86-A(11):2567.
298. Bhogal SSSK. Expectation and the placebo effect: how patients' expectation of receiving an active drug versus a placebo influences subjective and objective outcome measures. Senior Honours Thesis, Department of Psychology, The University of Western Ontario, London, Ontario, Canada April 2000.
299. Blue Cross Blue Shield Association Technology Evaluation Center. [Intra-articular hyaluronan injections for treatment of osteoarthritis of the knee]. TEC Assessment Program 1998; Vol. 15, issue 17:1-66.
300. Blue Cross Blue Shield Technology Evaluation Center. [Special Report: Intra-articular hyaluronan for osteoarthritis of the knee]. TEC Assessment Program December 2004.
301. Brandt KD, Smith GN Jr, Simon LS. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis. What is the evidence?. Arthritis & Rheumatism 2000;43(6):1192-203.
302. Brandt KD. [Non-surgical treatment of osteoarthritis: a half century of "advances"]. Annals of the Rheumatic Diseases 2004;63:117-22.
303. Brown DJ, Wood EV, Hannah HM, Rao VS, Teanby D. [Prospective comparison of sodium hyaluronate and hylan G-F 20 in a clinical practice: comment on the concise communication by Martens]. Arthritis & Rheumatism 2004;50(5):1697-8.
304. Brys DA. [Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee]. The Journal of Bone and Joint Surgery 2003;85-A(4):874-5.
305. Burns JW, Kraines JL, Magilavy DB, Murray CW, Richards SM. [Response to: identification of an immunogenic candidate for the elicitation of severe acute inflammatory reactions (SAIRs) to hylan G-F 20]. Osteoarthritis and Cartilage 2005;13(12):1128-9.
306. Charalambous CP. [Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee]. The Journal of Bone and Joint Surgery 2003;85-A(4):874.
307. Choi HK, Modawal A, Ferrer M, Caron JA. [A meta-analysis on the efficacy of intra-articular viscosupplementation therapy for knee osteoarthritis]. Arthritis & Rheumatism 1999;42 Suppl (9):293.
308. Cohen J. Statistical power analysis for the behavioural sciences. New York: Academic Press, 1977.
309. Collange C, Weyl-Clerc D. [Que penser des injections intra-articulaires dans le traitement de la gonarthrose]. In: MF Kahn, D Kuntz, O Meyer, Th Bardin, Ph Orcel, CI Guerin editor(s). L'actualities rhumatologique. Paris: Expansion Scientifique Francaise, 1999:422-34.
310. Denlinger JL. [Hyaluronan and its derivatives as viscoelastics in medicine]. In: Laurent TC editor(s). The Chemistry, Biology and Medical Applications of Hyaluronan and its Derivatives. London: Portland Press Ltd., 1998.
311. Dickerson K, Scherer R, Lefevbre C. [Identifying relevant studies for systematic reviews]. BMJ 1994;309:1286-91.
312. Dougados M. Sodium hyaluronate therapy in osteoarthritis: arguments for a potential beneficial structural effect. Seminars in Arthritis and Rheumatism 2000;30 Suppl (1):19-25.
313. Dougados M. Comparing different therapeutic classes for the treatment of osteoarthritis of the knee: data from the OMERACT-OARSI responder criteria analysis. Osteoarthritis and Cartilage 2005.
314. Dubey V, Glazier RH. [Intra-articular hyaluronic acid injections. Are they effective treatment for osteoarthritis of the knee?]. Canadian Family Physician 2003;49(April):435-7.
315. Espallargues M, Pons J.M.V. Efficacy and safety of viscosupplementation with Hylan G-F 20 for the treatment of knee osteoarthritis. A systematic review. International Journal of Technology Assessment in Health Care 2003;19(1):41-56.
316. Felson DT, Anderson JJ. [Hyaluronate sodium injections for osteoarthritis. Hope, hype, and hard truths]. Archives of Internal Medicine 2002;162:245-7.
317. Felson DT, Anerson JJ. [Hyaluronate sodium injections for osteoarthritis: the truth (In reply)]. Archives of Internal Medicine 2002;162:2499-500.
318. Galli M, De Santis V, Tafuro L. [Reliability of the Ahlback classification of knee osteoarthritis]. Osteoarthritis and Cartilage 2003;11:580-4.
319. Ghosh P, Guidolin D. [Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent?]. Seminars in Arthritis and Rheumatism 2002;32(1):10-37. [: doi:10.1053/sarh.2002.32549].
320. Goldsmith CH, Bellamy N, Pericak D, Torrance GW, Raynauld JP, Bell M, Polisson R. [Predictors of osteoarthritis (OA) improvement in patients treated with hylan G-F 20 for knee OA]. Osteoarthritis and Cartilage 2004;12 Suppl (2):77.
321. Gossec L, Dougados M. [Do intra-articular therapies work and who will benefit most?]. Best Practice & Research Clinical Rheumatology 2006;20(1):131-144.
322. Hamburger MI, Lakhanpal S, Mooar PA, Oster D. [Intra-articular hyaluronans: a review of product-specific safety profiles]. Seminars in Arthritis and Rheumatism 2003;32:296-309.
323. Hamburger MI. [Letter to the Editor: Response to the article by Raynauld et al.]. Osteoarthritis and Cartilage 2005;13(11):1039-40.
324. Hamburger M, Settles M, Teutsch J. [Author's reply to letter by Burns et al]. Osteoarthritis and Cartilage 2005;13(12):1130-1.
325. Hammesfahr JFR, Knopf AB, Stitik T. [Safety of intra-articular hyaluronates for pain associated with osteoarthritis of the knee]. The American Journal of Orthopedics 2003;32(6):277-83.
326. Haraoui B, Raynauld J-P. [Intra-articular therapy in osteoarthritis]. In: G.C. Tsokos editor(s). Modern Therapeutics in Rheumatic Diseases. Totowa, NJ: Humana Press, Inc., 2002:193-200.
327. Haynes RB, Wilczynski N, McKibbon KA, WalkerCJ, Sinclair JC. [Developing optimal search strategies for detecting clinically sound studies in MEDLINE]. Journal of the American Medical Informatics Association 1994;1:447-58.
328. Hedges LV, Olkin I. Statistical methods for metaanalysis. Orlando, FL: Academic Press, 1985.
329. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. [Measuring inconsistency in meta-analyses]. BMJ 2003;327:557-60.
330. Hochberg MC. Role of intra-articular hyaluronic acid preparations in medical management of osteoarthritis of the knee. Seminars in Arthritis and Rheumatism 2000;30 Suppl (1):2-10.
331. Hou S-M, Wang C-T. [Therapeutic effects of hyaluronic acid on osteoarthritis of the knee]. The Journal of Bone and Joint Surgery 2004;86-A(11):2567.
332. Hyalgan Premarket Approval Application: Summary of safety and effectiveness data. http://www.fda.gov/cdrh/pdf/p950027.pdf.
333. Ikeda K, et al.Changes in synovial fluid markers and clinical effect after intra-articular injection of sodium hyaluronate: with particulr reference to the anti-inflammatory effect in terms of prostaglandin E2 concentration. Journal of Tokyo Womens' Medical College 1998;68(1/2):22-36.
334. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary. Controlled Clinical Trials 1996;17:1-12.
335. Jones A, Regan M, Ledingham J, Pattrick M, Mantire A, Doherty M. [Importance of placement of intra-articular steroid injections]. BMJ 1993;307:1329-30.
336. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JWJ, Dieppe P, et al.[EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)]. Annals of the Rheumatic Diseases 2003;62:1145-55.
337. Kaptchuk TJ, Goldman P, Stone DA, Stason WB. [Do medical devices have enhanced placebo effects?]. Journal of Clinical Epidemiology 2000;53:786-92.
338. Kelly MA, Goldberg VM, Healy WL, Pagnano MW, Hamburger MI. [Osteoarthritis and beyond: a consensus on the past, present and future of hyaluronans in orthopedics]. Orthopedics 2003;26(10):1064-79.
339. Khanuja HS, Hungerford MW, Manjoo A. [Intraarticular injections for the treatment of osteoarthritis of the knee: basic science, results, and indications]. Current Opinion in Orthopaedics 2003;14(1):62-8.
340. Kirwan JR, Rankin E. Intra-articular therapy in osteoarthritis. Bailliere's Clinical Rheumatology 1997;11(4):769-94.
341. Kirwan J. Is there a place for intra-articular hyaluronate in osteoarthritis of the knee?. The Knee 2001;8(2):93-101.
342. Lequesne M. Clinical outcomes of intra-articular hyaluronan in the treatment of osteoarthritis of the knee. Immunology and Cell Biology 1996;74:A13-14.
343. Lo GH, LaValley MP, McAlindon TE, Felson DT. [Is intra-articular (IA) hyaluronic acid (HA) efficacious in treating knee osteoarthritis (OA)?]. Arthritis & Rheumatism 2002;47 Suppl (9):576.
344. Lo GH, La Valley M, McAlindon T, Felson DT. [Intra-articular hyaluronic acid in treatment of knee osteoarthritis. A meta-analysis]. JAMA 290(23):3115-21.
345. Lo GH, La Valley M, Felson DT. [Importance of intra-articular placebos in trials evaluating intra-articular therapies]. Arthritis & Rheumatism 2003;48(12):3618.
346. Lund T. [Some metrical issues with meta-analysis of therapy effects]. Scandinavian Journal of Psychology 1988;29:1-8.
347. Lussier A, Cividino AA, McFarlane CA, Olszynski WP, Potashner WJ, De Medicis R. Viscosupplementation with Hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. The Journal of Rheumatology 1996;23(9):1579-85.
348. Magilavy D, Polisson R, Parenti D. Re: Karlsson et al. Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology 2003;42(10):1262.
349. Maheu E, Lamotte J, Lequesne M. [Sel sodiuque de l'acide hyaluronique (hyaluronan) et gonarthrose]. In: S De Seze, A Ryckewaert, MF Kahn, D Kuntz, A Dryll, O Meyer, Th Bardin, CI Guerin editor(s). L'actualite rhumatologique. Paris: Expansion Scientifique Francaise ed., 1994:324-39.
350. Maheu E. Hyaluronan in knee osteoarthritis: a review of the clinical trials with Hyalgan. European Journal of Rheumatology and Inflammation 1995;15(1):17-24.
351. Maheu E, Ayral X, Dougados M. [A hyaluronan preparation (500-730 KDA) in the treatment of osteoarthritis: a review of clinical trials with hyalgan]. International Journal of Clinical Practice 2002;56(10):804-13.
352. Maheu E, Bonvarlet. [Acute pseudo-septic arthritis post hyaluronate (HA) intra-articular (IA) injections. Results of a French survey in rheumatology practice]. Annals of the Rheumatic Diseases 2003;EULAR, Lisbon, Portugal, June 18-21.
353. Maheu E. Hyaluronic acid in the treatment of osteoarthritis of the knee [L'acide hyaluronique dans le traitement de la gonarthrose]. Le journal francais de l'orthopedie [The French Orthopaedic web journal] at www.maitrise-orthop.com 2003.
354. Maneiro E, de Andres MC, Fernandez-Sueiro JL, Galdo F, Blanco FJ. [The biological action of hyaluronan on human osteoarthritic articular chondrocytes: the importance of molecular weight]. Clinical and Experimental Rheumatology 2004;22:307-12.
355. Marshall KW. Intra-articular hyaluronan therapy. Current Opinion in Rheumatology 2000;12:468-74.
356. Mazieres B, Bannwarth B, Dougados M, Lequesne M. [EULAR recommendations for the management of knee osteoarthritis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials]. Joint Bone Spine 2001;68:231-40.
357. McAuley L, Pham B, Tugwell P, Moher D. [Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses?]. Lancet 2000;356(9237):1228-31.
358. Middel B, van Sonderen E. [Statistical significant change versus relevant or important change in (quasi) experimental design: some conceptual and methodological problems in estimating magnitude of intervention-related change in health services research]. International Journal of Integrated Care 2002;2.
359. Modawal A, Ferrer M, Choi HK, Castle JA. [Hyaluronic acid injections relieve knee pain]. The Journal of Family Practice 2005;54(9):758-67.
360. Ontario Ministry of Health and Long-Term Care. Intra-articular injection of hylan G-F 20 for osteoarthritis of the knee. Government of Ontario, Canada 2005.
361. Moreland LW. [Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action]. Arthritis Research & Therapy 2003;5(2):54-67.
362. Moskowitz RW. [Hyaluronic acid supplementation]. Current Review of Rheumatology 2000;2:466-71.
363. Medical Services Advisory Committee. Intra-articular viscosupplementation for treatment of osteoarthritis of the knee. Commonwealth of Australia March 2003; Vol. MSAC application 1045, issue Assessment Report:88 pages.
364. Namiki O, Akiyama F, Hasegawa K, Rikimaru Y, Takahashi S. Properties of osteoarthritic synovial fluid and the metabolism of injected sodium hyaluronate. The Knee 1983;9(1):69-73.
365. Norman GR. [Issues in the use of change scores in randomized trials]. Journal of Clinical Epidemiology 1989;42(11):1097-105.
366. Orthovisc Premarket Approval Application: Summary of safety and effectiveness data. http://www.fda.gov/cdrh/pdf/p030019.pdf.
367. Pagnano M, Westrich G. Successful nonoperative management of chronic osteoarthritis pain of the knee: safety and efficacy of retreatment with intra-articular hyaluronans. Osteoarthritis and Cartilage 2005;13(9):751-761.
368. Pendleton A, Arden N, Dougados M, Doherty M, Bannwarth B, Bijlsma JWJ, et alelka K, Serni U, Swoboda B, Verbruggen AA, Weseloh G, Zimmermann-Gorska I. [EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)]. Annals of the Rheumatic Diseases 2000;43:1905-15.
369. Petitti DB. Meta-analysis, decision analysis, and cost-effectiveness analysis. Methods for quantitative synthesis in medicine. Monographs in epidemiology and biostatistics. Vol. 24, New York: Oxford University Press, Inc., 1994.
370. Peyron JG, Balazs EA. Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathologie-Biologie (Paris) 1974;22(8):731-6.
371. Peyron JG. Intraarticular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review. The Journal of Rheumatology 1993;20 Suppl (39):10-5.
372. Pisoni L, Schito E, De Lucia O, Murgo A, Paresce E. Osteoarthritis of the knee and local treatment [La gonartrosi ed il trattamento locale]. Artroscopia 2004;5(3):176-188.
373. Puhl W, Scharf P. [Intra-articular hyaluronan treatment for osteoarthritis]. Annals of the Rheumatic Diseases 1997;56(7):441.
374. Punzi L. The complexity of the mechanisms of action of hyaluronan in joint diseases. Clinical and Experimental Rheumatology 2001;19:242-6.
375. Puttick MPE, Wade JP, Chalmers A, Connell DG, Rangno KK. Acute local reactions after intraarticular hylan for osteoarthritis of the knee. The Journal of Rheumatology 1995;22(7):1311-4.
376. Raynauld JP, Olszynski WP, Goldsmith CH, Torrance GW, Bellamy N, Polission R, Pericak D, Walker V. [Effectiveness and safety of hylan G-F 20 compared to steroid injections in patients with knee osteoarthritis]. Arthritis & Rheumatism. 2003; Vol. 48 Suppl (9):484.
377. Raynauld JP, Goldsmith CH, Bellamy N, Torrance GW, Polisson R, Belovich D, Pericak D, Tugwell P. Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis. Osteoarthritis and Cartilage 2005;13(2):111-9.
378. Raynauld J-P, Goldsmith CH, Torrance GW for the Steering Committee and Clinical Investigators of the Canadian Knee OA Study Group. [Letter to the Editor: Reply to the letter by Max I. Hamburger]. Osteoarthritis and Cartilage 2005;13(12):1037-38.
379. Schulz KF, Chalmers I, Hayes RJ, Altman DG. [Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials]. JAMA 1995;273(5):408-12.
380. Schumacher Jr HR. [Aspiration and injection therapies for joints]. Arthritis & Rheumatism 2003;49(3):413-20.
381. Shinmei M, Inaoka M, Ukon Y, Shimomura Y, Tsuru S. Intra-articular injection therapy of high molecular weight sodium hyaluronate on osteoarthritis of the knee - clinical effects and change in synovial fluid properties. The Knee 1983;9(1):108-13.
382. Sokoloff L. Some highlights in the emergence of modern concepts of osteoarthritis. Seminars in Arthritis and Rheumatism 2001;31(2):71-107.
383. Stucki G, Daltroy L, Katz JN, Johannesson M, Liang MH. [Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts]. Journal of Clinical Epidemiology 1996;49(7):711-7.
384. Supartz Premarket Approval Application: Summary of safety and effectiveness data. http://www.fda.gov/cdrh/pdf/p980044.pdf.
385. Sutton AJ, Muir KR, Jones AC. [Two knees or one person: data analysis strategies for paired joints or organs]. Annals of the Rheumatic Diseases 1997;56:401-2.
386. Synvisc Hylan G-F 20 Premarket Approval Application: Summary of safety and effectiveness data. http://www.fda.gov/cdrh/pdf/p940015.pdf.
387. Tehranzadeh J, Booya F, Root J. Cartilage metabolism in osteoarthritis and the influence of viscosupplementation and steroid: a review. Acta Radiologica 2005;46(3):288-96.
388. Terrin N, Schmid CH, Lau J. [In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias]. Journal of Clinical Epidemiology 2005;58:894-01.
389. Towheed TE, Hochberg MC. A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the knee, with an emphasis on trial methodology. Seminars in Arthritis and Rheumatism 1997;25(5):755-70.
390. Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson DT, Hochberg M, van der Heijde D, Dougados M. [Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the Minimal Clinically Important Improvement]. Annals of the Rheumatic Diseases 2005;64(1):29-33.
391. Uebelhart D, WilliamsJM. [Effects of hyaluronic acid on cartilage degradation]. Current Opinion in Rheumatology 1999;11:427-35.
392. Ueno Y, Kuramoto K, Konno N, Koizumi T, Hoshiba T, Kamohara S, Koono M, Nunomura T, Futami M. Investigations on result of use after launch of ARTZ and ARTZ Dispo - evaluation on the efficacy, safety and utility in the medications for osteoarthritis of the knee and periarthritis of the shoulder. Japanese Pharmacology & Therapeutics 1995;23(8):2151-70.
393. Vickers AJ, Altman DG. [Analysing controlled trials with baseline and follow up measurements]. BMJ 2001;323:1123-4.
394. Waddell DD. [The tolerability of viscosupplementation: low incidence and clinical management of local adverse events]. Current Medical Research and Opinion 2003;19(7):575-80.
395. Walker-Bone K, Javaid K, Arden N, Cooper C. Medical management of osteoarthritis. BMJ 2000;321:936-40.
396. Wang C-T, Lin J, Chang C-J, Lin Y-T, Hou S-M. [Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials]. The Journal of Bone and Joint Surgery 2004;86-A(3):538-45.
397. Watterson JR, Esdaile JM. Viscosupplementation: Therapeutic mechanisms and clinical potential in osteoarthritis of the knee. Journal of the American Academy of Orthopedic Surgeons 2000;8(5):277-84.
398. Weiss C, Band P. [Basic principles underlying the development of viscosupplementation for the treatment of osteoarthritis]. Journal of Clinical Rheumatology 1999;5 Suppl:2-11.
399. Wen DY. [Intra-articular hyaluronic acid injections for knee osteoarthritis]. American Family Physician 2000;62(3):565-70.
400. Wind Jr. WM, Smolinski RJ. [Reliability of common knee injection sites with low-volume injections]. The Journal of Arthroplasty 2004;19(7):858-61.
401. Zhang Y, Glynn RJ, Felson DT. [Musculoskeletal disease research: should we analyze the joint or the person?]. The Journal of Rheumatology 1996;23(7):1130-4.
402. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G. [Viscosupplementation for the treatment of osteoarthritis of the knee]. The Cochrane Database of Systematic Reviews 2005, (2). [MEDLINE: CD005321;: DOI:10.1002/14651858.CD005321].